Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (491-500 of 891) with videos related to

Pageof 90
Sort By:
Bone Marrow Transplantation|June 1, 1996
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignanciesJ M Vose, P J Bierman, E Ruby, et al.
Plos One|November 29, 2018
Zinc enhances hippocampal long-term potentiation at CA1 synapses through NR2B containing NMDA receptorsJohn A Sullivan, Xiao-Lei Zhang, Arthur P Sullivan, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|May 26, 2018
Swallowing Kinematic Differences Across Frozen, Mixed, and Ultrathin Liquid Boluses in Healthy Adults: Age, Sex, and Normal VariabilityIanessa A Humbert, Kirstyn L Sunday, Eleni Karagiorgos, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2014
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokineticsCarla Casulo, Julie M Vose, William Y Ho, et al.
Bone Marrow Transplantation|July 23, 1998
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two casesR J Hauke, T C Greiner, B N Smir, et al.
Experimental Neurology|May 5, 2021
Single-session effects of acute intermittent hypoxia on breathing function after human spinal cord injuryTommy Sutor, Kathryn Cavka, Alicia K Vose, et al.
Seminars in Hematology|April 1, 1994
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study GroupJ M Vose, J R Anderson, P J Bierman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2001
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based reviewT Hahn, S N Wolff, M Czuczman, et al.
International Journal of Food Microbiology|April 15, 2008
Quantitative modeling for risk assessment of Vibrio parahaemolyticus in bloody clams in southern ThailandAkio Yamamoto, Jun'ichiro Iwahori, Varaporn Vuddhakul, et al.
Leukemia & Lymphoma|September 18, 2012
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation studyJulie M Vose, Jonathan W Friedberg, Edmund K Waller, et al.
Pageof 90

Showing results (491-500 of 891) with videos related to

Sort By:
Pageof 90
Bone Marrow Transplantation|June 1, 1996
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignanciesJ M Vose, P J Bierman, E Ruby, et al.
Plos One|November 29, 2018
Zinc enhances hippocampal long-term potentiation at CA1 synapses through NR2B containing NMDA receptorsJohn A Sullivan, Xiao-Lei Zhang, Arthur P Sullivan, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|May 26, 2018
Swallowing Kinematic Differences Across Frozen, Mixed, and Ultrathin Liquid Boluses in Healthy Adults: Age, Sex, and Normal VariabilityIanessa A Humbert, Kirstyn L Sunday, Eleni Karagiorgos, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2014
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokineticsCarla Casulo, Julie M Vose, William Y Ho, et al.
Bone Marrow Transplantation|July 23, 1998
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two casesR J Hauke, T C Greiner, B N Smir, et al.
Experimental Neurology|May 5, 2021
Single-session effects of acute intermittent hypoxia on breathing function after human spinal cord injuryTommy Sutor, Kathryn Cavka, Alicia K Vose, et al.
Seminars in Hematology|April 1, 1994
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study GroupJ M Vose, J R Anderson, P J Bierman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2001
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based reviewT Hahn, S N Wolff, M Czuczman, et al.
International Journal of Food Microbiology|April 15, 2008
Quantitative modeling for risk assessment of Vibrio parahaemolyticus in bloody clams in southern ThailandAkio Yamamoto, Jun'ichiro Iwahori, Varaporn Vuddhakul, et al.
Leukemia & Lymphoma|September 18, 2012
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation studyJulie M Vose, Jonathan W Friedberg, Edmund K Waller, et al.
Pageof 90